Recent advances and future perspectives in the therapeutics of prostate cancer.

Publication Year: 2023

DOI:
10.1186/s40164-023-00444-9

PMCID:
PMC10517568

PMID:
37740236

Journal Information

Full Title: Exp Hematol Oncol

Abbreviation: Exp Hematol Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interests:The authors declare that they have no potential conflicts of interest. Competing interests: The authors declare that they have no potential conflicts of interest."

Evidence found in paper:

"Funding This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) Grant funded by the Korea government (MSIT) (2021R1A5A6002853 and 2022M3J7A1062940). This work was also supported by a Grant from the Korea Environmental Industry and Technology Institute (KEITI), funded by the Ministry of Environment (MOE) of the Republic of Korea (RE202201777)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025